U.S. Markets open in 4 hrs 10 mins

Cardiovascular Systems, Inc. (CSII)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
30.19-0.32 (-1.05%)
At close: 4:00PM EDT
People also watch
SPNCATRCELGXCNMDPODD

Cardiovascular Systems, Inc.

1225 Old Highway 8 Northwest
St. Paul, MN 55112
United States
651-259-1600
http://www.csi360.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees581

Key Executives

NameTitlePayExercisedAge
Mr. Scott Raymond Ward MS, B.Sc.Chairman, Chief Exec. Officer and Pres548.46kN/A58
Mr. Laurence L. BetterleyChief Financial Officer493.8kN/A63
Mr. Kevin J. KennyChief Operating Officer651.3kN/A52
Mr. Paul A. KoehnSr. VP of Manufacturing, Operations and Quality426.21kN/A54
Mr. Jack E. NielsenSr. Director of Corp. Communications & IRN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cardiovascular Systems, Inc., a medical technology company, develops, manufactures, and markets devices to treat vascular diseases in the United States. It offers peripheral arterial disease products, including Diamondback 360 Peripheral Orbital Atherectomy System (OAS), Stealth 360° Peripheral OAS, Diamondback 360 60cm Peripheral OAS, Diamondback 360 Low Profile Peripheral OAS, Diamondback 360 1.50 Peripheral OAS, and Diamondback 360 2.00 Peripheral OAS, which are catheter-based platforms for treating a range of plaque types, such as calcified plaque, in leg arteries both above and below the knee and address many of the limitations associated with other surgical, catheter, and pharmacological treatment alternatives, as well as Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries. The company sells its products directly to hospitals or office-based labs. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.

Corporate Governance

Cardiovascular Systems, Inc.’s ISS Governance QualityScore as of May 1, 2017 is 5. The pillar scores are Audit: 2; Board: 3; Shareholder Rights: 6; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.